Pharmacogenetic Study in Patients Received Iron Chelating Agent
NCT01623895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2014-07-14
Summary
To investigate effect of genetic variations on the toxicities and find optimal target population, the investigators planned to analyze the genetic polymorphisms of UDP-glucuronosyltransferase.
Conditions
- Hemosiderosis
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT01131624 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Iron Deficiency Anaemia in Pregnancy Study
NCT03725150 ·Status: COMPLETED
-
The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
NCT05370677 ·Status: UNKNOWN
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Transferrin Saturation and Asthenia in Hemochromatosis
NCT03356548 ·Status: COMPLETED
-
Molecular Biology of Polycythemia and Thrombocytosis
NCT00722527 ·Status: RECRUITING
-
Treatment of Hemochromatosis
NCT00007150 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment of Iron Deficiency Anemia With Pregnancy
NCT02005588 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Transferrin Saturation Coefficient and Ferritinemia in Diagnosis of Iron Deficiency
NCT04139265 ·Status: COMPLETED
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Cohort of Patients With Rare Iron Overloads Excluding C282Y Homozygosity
NCT02619955 ·Status: COMPLETED
-
Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
NCT04779593 ·Status: RECRUITING ·Phase: NA
-
Iron Deficiency Anemia in Childern With Liver Cirrhosis
NCT03482076 ·Status: UNKNOWN ·Phase: NA
-
Different Iron Supplements for Prevention of Anemia in Pregnancy
NCT02487719 ·Status: UNKNOWN ·Phase: PHASE4
-
Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
NCT01556360 ·Status: COMPLETED
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
NCT05157828 ·Status: COMPLETED
-
Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
NCT05440487 ·Status: COMPLETED
-
Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose
NCT01978028 ·Status: TERMINATED ·Phase: PHASE4
-
Hemochromatosis--Genetic Prevalence and Penetrance
NCT00006312 ·Status: COMPLETED
-
Early Antenatal Support for Iron Deficiency Anemia
NCT04278651 ·Status: RECRUITING ·Phase: PHASE4
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
NCT00982007 ·Status: COMPLETED ·Phase: PHASE3
-
Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy
NCT06252103 ·Status: COMPLETED ·Phase: PHASE4
-
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 ·Status: UNKNOWN